American Century Companies’s NovoCure NVCR Stock Holding History

American Century Companies’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$795K	Sell	52,473 -146,265	-74%	-$2.21M	﹤0.01%	2474
2026 Q1	$2.17M	Sell	198,738 -842,794	-81%	-$10.5M	﹤0.01%	2087
2025 Q4	$13.5M	Sell	1,041,532 -177,275	-15%	-$2.28M	0.01%	1323
2025 Q3	$15.7M	Buy	1,218,807 +188,933	+18%	+$2.52M	0.01%	1245
2025 Q2	$18.3M	Buy	1,029,874 +959,079	+1,355%	+$16.7M	0.01%	1134
2025 Q1	$1.26M	Buy	+70,795	New	+$1.61M	﹤0.01%	2174
2023 Q2	–	Sell	-14,770	Closed	-$888K	–	2825
2023 Q1	$888K	Buy	14,770 +3,966	+37%	+$317K	﹤0.01%	1907
2022 Q4	$792K	Sell	10,804 -2,670	-20%	-$201K	﹤0.01%	1881
2022 Q3	$1.02M	Buy	13,474 +2,347	+21%	+$183K	﹤0.01%	1681
2022 Q2	$773K	Buy	11,127 +6,377	+134%	+$480K	﹤0.01%	1748
2022 Q1	$393K	Buy	4,750 +3	+0.1%	+$221	﹤0.01%	2038
2021 Q4	$356K	Hold	4,747	–	–	﹤0.01%	2058
2021 Q3	$551K	Sell	4,747 -5,376	-53%	-$813K	﹤0.01%	1845
2021 Q2	$2.25M	Sell	10,123 -1,812	-15%	-$352K	﹤0.01%	1219
2021 Q1	$1.58M	Sell	11,935 -28,940	-71%	-$4.58M	﹤0.01%	1253
2020 Q4	$7.07M	Buy	40,875 +24,211	+145%	+$3.31M	0.01%	825
2020 Q3	$1.85M	Sell	16,664 -11,620	-41%	-$929K	﹤0.01%	989
2020 Q2	$1.68M	Sell	28,284 -22,085	-44%	-$1.45M	﹤0.01%	961
2020 Q1	$3.39M	Buy	+50,369	New	+$3.98M	﹤0.01%	777

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

American Century Companies's NVCR Position: Q2 2026 in Review

American Century Companies reduced its NovoCure (NVCR) stake by 74% in Q2 2026, selling an estimated $2.21M and leaving 52,473 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #2474.

American Century Companies first reported a position in NVCR in Q1 2020 and has held it in 19 quarters since. The position peaked at $18.3M in Q2 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

American Century Companies held 52,473 shares of NovoCure worth $795K as of Q2 2026.
American Century Companies sold 146,265 NovoCure shares in Q2 2026, an estimated $2.21M.
NovoCure made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2474 holding.
American Century Companies first reported a position in NovoCure in Q1 2020 and has held it in 19 quarters since.
American Century Companies's NovoCure position peaked at $18.3M in Q2 2025.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.